Literature DB >> 11719138

Dantrolene ameliorates delayed cell death and concomitant DNA fragmentation in the rat hippocampal CA1 neurons subjected to mild ischemia.

T Yano1, R Nakayama, T Imaizumi, H Terasaki, K Ushijima.   

Abstract

The present study investigated whether dantrolene, which inhibits the Ca(2+) release from the intracellular Ca(2+) store sites, reduced nuclear DNA fragmentation and produced neuronal protection in a model of global forebrain ischemia. Male Wistar rats were subjected to four-vessel occlusion (4VO) for 5 min and then infused continuously with dantrolene or vehicle into the cerebral ventricle for 3 days. The intact rats did not undergo any intervention. The number of viable and DNA nick-end-labeled neurons in the hippocampal CA1 were evaluated 4 days after the ischemia. The number of viable neurons in the dantrolene-treated rats was significantly higher than that in the vehicle-treated rats and lower than that in the intact animals (P<0.01 and <0.05, respectively). The number of DNA nick-end-labeled nuclei was significantly lower in dantrolene-treated rats compared with the vehicle-treated animals (P<0.0001). No nick-end labeling was observed in the intact animals. A linear correlation was found between the number of viable cells and nick-end labeled nuclei in the CA1 (r=0.91, P<0.0001). These results suggest that the postischemic intraventricular dantrolene is effective in precluding neuronal death and concomitant nuclear DNA fragmentation following transient global ischemia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11719138     DOI: 10.1016/s0300-9572(00)00369-5

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  9 in total

1.  Effects of dantrolene on apoptosis and immunohistochemical expression of NeuN in the spinal cord after traumatic injury in rats.

Authors:  Bruno Benetti Junta Torres; Fátima Maria Caetano Caldeira; Mardelene Geísa Gomes; Rogéria Serakides; Aline de Marco Viott; Angélica Cavalheiro Bertagnolli; Fabíola Bono Fukushima; Karen Maciel de Oliveira; Marcus Vinícius Gomes; Eliane Gonçalves de Melo
Journal:  Int J Exp Pathol       Date:  2010-10-05       Impact factor: 1.925

2.  Evidence for a role of second pathophysiological stress in prevention of delayed neuronal death in the hippocampal CA1 region.

Authors:  Jozef Burda; Milina Matiasová; Miroslav Gottlieb; Viera Danielisová; Miroslava Némethová; Lidia Garcia; Matilde Salinas; Rastislav Burda
Journal:  Neurochem Res       Date:  2005-11       Impact factor: 3.996

3.  Effects of a single dose of dantrolene in patients with cerebral vasospasm after subarachnoid hemorrhage: a prospective pilot study.

Authors:  Susanne Muehlschlegel; Guy Rordorf; John Sims
Journal:  Stroke       Date:  2011-03-31       Impact factor: 7.914

4.  Long-term dantrolene treatment reduced intraneuronal amyloid in aged Alzheimer triple transgenic mice.

Authors:  Zhen Wu; Bin Yang; Chunxia Liu; Ge Liang; Maryellen F Eckenhoff; Weixia Liu; Stephen Pickup; Qingcheng Meng; Yuke Tian; Shitong Li; Huafeng Wei
Journal:  Alzheimer Dis Assoc Disord       Date:  2015 Jul-Sep       Impact factor: 2.703

5.  Dantrolene mediates vasorelaxation in cerebral vasoconstriction: a case series.

Authors:  Susanne Muehlschlegel; Guy Rordorf; Michael Bodock; John R Sims
Journal:  Neurocrit Care       Date:  2008-08-12       Impact factor: 3.210

6.  Could dantrolene be explored as a repurposed drug to treat COVID-19 patients by restoring intracellular calcium homeostasis?

Authors:  B Jiang; S Liang; G Liang; H Wei
Journal:  Eur Rev Med Pharmacol Sci       Date:  2020-10       Impact factor: 3.507

Review 7.  Dantrolene: mechanisms of neuroprotection and possible clinical applications in the neurointensive care unit.

Authors:  Susanne Muehlschlegel; John R Sims
Journal:  Neurocrit Care       Date:  2008-08-12       Impact factor: 3.532

Review 8.  The cytoprotective effects of dantrolene: a ryanodine receptor antagonist.

Authors:  Saadet Inan; Huafeng Wei
Journal:  Anesth Analg       Date:  2010-09-22       Impact factor: 6.627

Review 9.  Revisiting Excitotoxicity in Traumatic Brain Injury: From Bench to Bedside.

Authors:  Daniela Baracaldo-Santamaría; Daniel Felipe Ariza-Salamanca; María Gabriela Corrales-Hernández; Maria José Pachón-Londoño; Isabella Hernandez-Duarte; Carlos-Alberto Calderon-Ospina
Journal:  Pharmaceutics       Date:  2022-01-08       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.